Search results
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 5 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required SARS-...
National Academies Issue New Broad Definition of Long COVID
Medscape· 1 day agoAccording to the 2024 NASEM definition of long COVID issued on June 11, 2024, "Long COVID is an...
COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022
Centers for Disease Control and Prevention· 5 days agoIn addition, access to provisional death certificates is a consistently expeditious method for obtaining reports of potential COVID-19–associated deaths. In our analysis, median days between ...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 5 days agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...
CureVac (NASDAQ:CVAC) Sees Strong Trading Volume
ETF DAILY NEWS· 4 days agoCureVac (NASDAQ:CVAC – Get Free Report) saw strong trading volume on Thursday . 975,123 shares traded hands during mid-day trading, a decline of 0% from the previous session’s volume of 975,509 ...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Northern Trust Corp
ETF DAILY NEWS· 2 days agoNorthern Trust Corp reduced its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 6.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,708,357 shares ...
Chronotherapy: Why Timing Drugs to Our Body Clocks May Work
Medscape· 2 days agoA new analysis published in this month's issue of The Lancet journal's eClinicalMedicine suggests:...
Parallel Advisors LLC Purchases 1,015 Shares of Xencor, Inc. (NASDAQ:XNCR)
ETF DAILY NEWS· 2 days agoParallel Advisors LLC increased its stake in Xencor, Inc. (NASDAQ:XNCR – Free Report) by 303.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,349 shares of the biopharmaceutical ...
TD Asset Management Inc Sells 56,914 Shares of Xencor, Inc. (NASDAQ:XNCR)
ETF DAILY NEWS· 4 days agoThe fund owned 123,250 shares of the biopharmaceutical company’s stock after selling 56,914 shares during the quarter. TD Asset Management Inc’s holdings in Xencor were worth $2< ...